Cargando…

Medication-assisted quit rates in participants with smoking-related diseases in EAGLES: Post hoc analyses of a double-blind, randomized, placebo-controlled clinical trial

INTRODUCTION: Greater understanding is required of how smokers with smoking-related diseases respond to smoking cessation medications. This post hoc analysis of EAGLES data compared continuous abstinence rates (CARs) in smokers with/without smoking-related diseases and assessed participant demograph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tønnesen, Philip, Lawrence, David, Tonstad, Serena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID) 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086158/ https://www.ncbi.nlm.nih.gov/pubmed/35611069 http://dx.doi.org/10.18332/tid/146567

Ejemplares similares

Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial
por: Fagerström, Karl, et al.
Publicado: (2010)

Cue restricted smoking increases quit rates with varenicline
por: Scholz, Jaqueline R., et al.
Publicado: (2021)

Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial
por: Tønnesen, Philip, et al.
Publicado: (2012)

Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo‐controlled studies of varenicline
por: Tonstad, Serena, et al.
Publicado: (2016)

Measurement of factors that negatively influence the outcome of quitting smoking among patients with COPD: psychometric analyses of the Try To Quit Smoking instrument
por: Lundh, Lena, et al.
Publicado: (2014)

Seasonal Antimicrobial Activity of the Airway: Post-Hoc Analysis of a Randomized Placebo-Controlled Double-Blind Trial
por: Vargas Buonfiglio, Luis G., et al.
Publicado: (2020)

Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active‐ and placebo‐controlled EAGLES trial
por: Ayers, Catherine R., et al.
Publicado: (2019)

Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES
por: West, Robert, et al.
Publicado: (2018)

Quitting smoking: the benefits
Publicado: (2017)

Melatonin in Assisted Reproductive Technology: A Pilot Double-Blind Randomized Placebo-Controlled Clinical Trial
por: Fernando, Shavi, et al.
Publicado: (2018)

Body mass index and age correlate with antioxidant supplementation effects on sperm quality: Post hoc analyses from a double‐blind placebo‐controlled trial
por: Busetto, Gian Maria, et al.
Publicado: (2020)

Recommendations to improve smoking cessation outcomes from people with lung conditions who smoke
por: Masefield, Sarah, et al.
Publicado: (2016)

The efficacy of extended-release levomilnacipran in moderate to severe major depressive disorder: secondary and post-hoc analyses from a randomized, double-blind, placebo-controlled study
por: Montgomery, Stuart A., et al.
Publicado: (2014)

Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study
por: Sauder, Colin, et al.
Publicado: (2022)

Sex effects in predictors of smoking abstinence and neuropsychiatric adverse events in the EAGLES trial()
por: McKee, Sherry A., et al.
Publicado: (2023)

A Randomized Placebo-Controlled Trial of Varenicline for Smoking Cessation Allowing Flexible Quit Dates
por: Rennard, Stephen, et al.
Publicado: (2012)

Randomized, placebo-controlled, double-blind trial of Swedish snus for smoking reduction and cessation
por: Joksić, Gordana, et al.
Publicado: (2011)

Who Participates in Web-Assisted Tobacco Interventions? The Quit-Primo and National Dental Practice-Based Research Network Hi-Quit Studies
por: Sadasivam, Rajani Shankar, et al.
Publicado: (2013)

Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials
por: Alev, Levent, et al.
Publicado: (2017)

Quit Now? Quit Soon? Quit When You’re Ready? Insights About Target Quit Dates for Smoking Cessation From an Online Quit Date Tool
por: Cobb, Caroline O, et al.
Publicado: (2014)

Readiness to Quit Smoking and Quit Attempts Among Australian Mental Health Inpatients
por: Stockings, Emily, et al.
Publicado: (2013)

Smoking, alcohol, and substance use and rates of quitting during pregnancy: is it hard to quit?
por: Yazici, Ahmet Bulent, et al.
Publicado: (2016)

Effects of typhoid vaccine on inflammation and sleep in healthy participants: a double-blind, placebo-controlled, crossover study
por: Sharpley, Ann L., et al.
Publicado: (2016)

Quit Smoking and Run For Your Life!
por: Mathew, BC, et al.
Publicado: (2008)

Predictors of Quitting Smoking in Cardiac Rehabilitation
por: Salman, Ahmad, et al.
Publicado: (2020)

Factors Associated With Quitting Smoking in Indonesia
por: Sadarang, Rimawati Aulia Insani
Publicado: (2021)

COVID-19 and smoking: An opportunity to quit()
por: Pastor Esplá, Esther, et al.
Publicado: (2021)

“Look at Me, I Plan to Quit Smoking”: Bayesian Hierarchical Analysis of Adolescent Smokers’ Intention to Quit Smoking
por: Ng’ombe, John N., et al.
Publicado: (2020)

Efficacy and safety of guanfacine extended‐release in Japanese adults with attention‐deficit/hyperactivity disorder: Exploratory post hoc subgroup analyses of a randomized, double‐blind, placebo‐controlled study
por: Naya, Noriyuki, et al.
Publicado: (2020)

Eagle syndrome: An updated review
por: Pagano, Serena, et al.
Publicado: (2023)

Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial
por: Rahman, Farah, et al.
Publicado: (2022)

The Eagle Has Landed: an unusual case of Eagle’s syndrome
por: AlAbdulwahed, Reem, et al.
Publicado: (2021)

Is the motivation to quit smoking greater if the smoker is going to quit smoking of their own free will or when advised by a health professional?
por: de Granda-Orive, José I., et al.
Publicado: (2022)

The Association of Peer Smoking Behavior and Social Support with Quit Success in Employees Who Participated in a Smoking Cessation Intervention at the Workplace
por: van den Brand, Floor A., et al.
Publicado: (2019)

A Randomized, Double‐Blind, Placebo‐ and Positive‐Controlled, 4‐Period Crossover Study of the Effects of Solriamfetol on QTcF Intervals in Healthy Participants
por: Zomorodi, Katie, et al.
Publicado: (2020)

Determinants of Smoking and Quitting in HIV-Infected Individuals
por: Regan, Susan, et al.
Publicado: (2016)

Race/ethnicity and intention to quit cigarette smoking
por: Soulakova, Julia N., et al.
Publicado: (2016)

A Report on Smoking Detection and Quitting Technologies
por: Ortis, Alessandro, et al.
Publicado: (2020)

Discrimination, Mental Health, and Readiness to Quit Smoking
por: Jones-Patten, Alexandria, et al.
Publicado: (2023)

The eagle's throne /
por: Fuentes, Carlos
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_4tgtbp1l79oha953vbu944gc3v